CONDUENT Inc Q3 FY2026 earnings call

• Strategic Execution: CEO Harsha Agadi emphasized the 'Ascend 2026-2028' plan, focusing on converting a $2.9 billion qualified pipeline into sustainable growth, optimizing the portfolio by exiting transportation, and enforcing financial discipline.
• Portfolio Optimization: Completed the sale of the public transit business to Modaxo for $164 million; expect to close the tolling business sale shortly. These moves sharpen focus on core commercial and government segments.
• AI & Technology: Established an AI Center of Excellence to scale GenAI for unstructured document processing and fraud detection, aiming to enhance productivity and development speed.
• Financial Restructuring: Completed refinancing of revolving credit facilities to $447 million with maturity extended to May 2029, improving liquidity and flexibility.
• Cost Reduction: Identified $106 million of cost savings against a $120 million target, having realized $55 million so far. Capital expenditures are being tightened, with YTD spending at $38 million vs $59 million prior year.
• Litigation Resolution: Reached an agreement to settle class action litigation from the Jan 2025 cyber event, expected to be fully funded by insurance.

The company reports revenue from continuing operations of $534 million, up sequentially from Q2 2026 but down year-over-year from $605 million in Q3 2025. Adjusted EBITDA was $36 million (margin of 6.7%), up from $31 million (5.1% margin) in Q3 2025. The Commercial segment generated $308 million in revenue (down 16% YoY) and $29 million in Adjusted EBITDA (margin 9.4%, down 70 bps YoY). The Government segment generated $226 million in revenue (down from $238 million YoY) and $63 million in Adjusted EBITDA (margin 27.9%, up 230 bps YoY). Unallocated costs were $56 million.

• Full-year 2026 Revenue Guidance remains unchanged at $2.15 to $2.25 billion.
• Full-year 2026 Adjusted EBITDA Guidance remains unchanged at $140 to $170 million (midpoint ~7% margin).
• Management expects adjusted EBITDA margins to incrementally improve to double digits over the three-year outlook.
• Target to deliver positive free cash flow within the 2026-2028 timeframe.
• Net leverage ratio is expected to decrease to 1.5 turns by 2028 and further to 1.0 turn thereafter.

• Revenue Churn: Significant headwinds from historical churn, including the loss of a largest commercial client whose contract ended in Q3.
• Deal Cycle Delays: Average deal cycle times have increased, particularly in the government segment, due to state election cycles slowing procurement and award timing.
• Cash Flow Volatility: Temporary negative adjusted free cash flow (-$117 million) driven by the pausing of factoring programs during refinancing negotiations.
• Pipeline Conversion: While the pipeline is strong ($2.9 billion), management acknowledges the need to improve win rates and conversion velocity to drive top-line growth.

Q: Analyst asked about the timing of new ACV wins flowing through to the P&L given that revenue remains down despite new business signings.

A: CEO clarified that new ACV is already contributing, but the sequential improvement reflects the net effect after a large customer cycled off. With that major churn event complete, future new wins are expected to exceed remaining churn, driving sustained sequential revenue growth.

Q: Analyst inquired about revenue recognition methods for the Virginia Medicaid modernization project and how pricing/renewal terms compare to previous contracts.

A: CFO stated Virginia revenue is recognized on a percentage-of-completion basis. Regarding pricing, management noted they are capturing inflationary increases and insisting on COLA clauses. Renewals in commercial are typically 3-year terms, while government renewals often involve shorter-term add-ons due to election-related delays in larger awards.

Q: Analyst sought details on the $2.9 billion qualified pipeline, catalysts for conversion, and reasons for extended average deal cycle times.

A: CEO explained the pipeline includes ~$2.5B in government and $400M in commercial, all in advanced stages. He highlighted that post-election cycles will unlock approvals for ~30 proposals worth $380M, creating upside. CFO confirmed election cycles were the primary cause for longer deal cycles, which should normalize now.

Q: Analyst asked about pricing dynamics for next year's plan and whether pricing power can be captured in key business areas.

A: CEO emphasized that while competitive, the company leverages inflation pass-throughs and COLA clauses. Furthermore, using better technology platforms lowers internal costs, allowing for more competitive bidding. Management focuses on absolute dollar contribution margin per deal rather than just margin percentages.